Package 80425-0208-2

{"route": ["ORAL"], "spl_id": "2a99c0c8-93bb-9e14-e063-6394a90a332b", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["eca774cf-2e4e-7642-e053-2a95a90a847d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Advanced Rx Pharmacy of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (80425-0208-1)", "package_ndc": "80425-0208-1", "marketing_start_date": "20240225"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (80425-0208-2)", "package_ndc": "80425-0208-2", "marketing_start_date": "20230331"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (80425-0208-3)", "package_ndc": "80425-0208-3", "marketing_start_date": "20230331"}], "brand_name": "Topiramate", "product_id": "80425-0208_2a99c0c8-93bb-9e14-e063-6394a90a332b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "80425-0208", "generic_name": "Topiramate", "labeler_name": "Advanced Rx Pharmacy of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140614", "listing_expiration_date": "20261231"}